Navigation Links
CSL Behring Receives Orphan-Drug Exclusivity for RiaSTAP(TM), First and Only Approved Treatment of Acute Bleeding Episodes in Patients with Congenital Fibrinogen Deficiency
Date:3/11/2009

taneous bleeding and bone, joint or tissue hemorrhage. Diminished concentrations of fibrinogen, also called Factor I (one), limit the body's ability to form a clot. Certain fibrinogen levels usually indicate normal blood clotting ability. To determine fibrinogen levels and confirm a diagnosis, blood coagulation testing is needed.

RiaSTAP is a purified fibrinogen concentrate that undergoes virus inactivation and removal for safety assurance. There have been more than 1 million units sold worldwide (marketed outside the U.S. under the trade name Haemocomplettan(R) P). CSL Behring is studying RiaSTAP in an ongoing post-marketing commitment study to further demonstrate safety and hemostatic efficacy.

About RiaSTAP

RiaSTAP is a purified fibrinogen concentrate indicated for the treatment of acute bleeding episodes in patients with congenital fibrinogen deficiency, including afibrinogenemia and hypofibrinogenemia. RiaSTAP is not indicated for dysfibrinogenemia. RiaSTAP is contraindicated in individuals who have had severe immediate hypersensitivity reactions, including anaphylaxis to RiaSTAP or its components.

Physicians should monitor patients for early signs of allergic or hypersensitivity reactions and if necessary, discontinue administration and institute appropriate treatment. Thrombotic events have been reported in patients receiving RiaSTAP. Physicians should weigh the benefits of administration versus the risks of thrombosis.

RiaSTAP is made from pooled human plasma. Products made from human plasma may contain infectious agents (e.g., viruses and theoretically the Creutzfeldt-Jakob disease agent (CJD) that can cause disease. The risk that such products will transmit an infectious agent has been reduced by screening plasma donors for prior exposure to certain viruses, by testing for the presence of certain current virus infections, and by a process demonstrated to inactivate
'/>"/>

SOURCE CSL Behring
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Over $10 Million of CSL Behrings Privigen Was Sold in the U.S. During the Third Quarter of 2008
2. CSL Behring Submits BLA Requesting Approval of C1-Esterase Inhibitor for the Treatment of Hereditary Angioedema
3. CSL Behring Study in Animal Models Shows Feasibility of Developing a Half-Life Extended Recombinant FVIIa that Retains Biologic Activity
4. CSL Behring Reaches Primary Endpoint in Clinical Study of C1-INH for Treatment of Hereditary Angioedema
5. Childrens Hospital Receives $6.7 Million Grant From Gates Foundation to Study Influenza Vaccine in Pregnant Women in Asia
6. deCODE Receives California Clinical Laboratory License
7. Omeros Receives $3.1 Million Milestone Payment from The Stanley Medical Research Institute for Schizophrenia Program
8. Phico Therapeutics Receives GBP1 Million Award From the Wellcome Trust to Take Anti-MRSA Nasal Product Through Early Clinical Trials
9. PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications
10. Kiadis Pharma Receives Two Orphan Drug Designations for Reviroc(TM) From the FDA
11. Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... NASHVILLE, Tenn., Dec. 15 Cumberland ... announced new top-line results for a ... for Oral Solution, a prescription laxative packaged as ... liquid forms. ,, Kristalose is the only prescription-strength ... 14-day period, 50 patients with a recent diagnosis ...
(Date:12/15/2009)... healthcare providers who have already immunized patients most ... virus may now offer the vaccine to anyone ... today. ,, Pennsylvania is expanding the H1N1 ... doses of vaccine have been allocated to healthcare ... priority groups. ,, "Many certified providers have already ...
(Date:12/15/2009)... Fenwal Inc., a global medical technology ... and availability, announced today that the U.S. Food ... market InterSol ® platelet additive solution. ... a specialized product used in combination with human ... component used to prevent or treat bleeding. ,, ...
Breaking Medicine Technology:Kristalose(R) Preferred by Patients With Chronic Constipation Compared to Similar Products in a Recent Study 2Kristalose(R) Preferred by Patients With Chronic Constipation Compared to Similar Products in a Recent Study 3Department of Health Urges Expanded H1N1 Vaccination Efforts to Include All Patients 2Fenwal Receives FDA Approval for New Solution Used to Store Donated Blood Platelets 2Video 3A Project Runway Designer Launches New Online Video Series to Educate About Living with HIV and AIDS and Help Combat HIV Stigma 55866 1Video 3A Project Runway Designer Launches New Online Video Series to Educate About Living with HIV and AIDS and Help Combat HIV Stigma 55866 2Video 3A Project Runway Designer Launches New Online Video Series to Educate About Living with HIV and AIDS and Help Combat HIV Stigma 55866 37 Days Across America Campaign Honors Teens Making a Difference in Their Communities 55864 17 Days Across America Campaign Honors Teens Making a Difference in Their Communities 55864 27 Days Across America Campaign Honors Teens Making a Difference in Their Communities 55864 37 Days Across America Campaign Honors Teens Making a Difference in Their Communities 55864 4RJR Other Tobacco Companies Go to Court to Evade Regulation by FDA 55862 1RJR Other Tobacco Companies Go to Court to Evade Regulation by FDA 55862 2
... Superbugs and Superdrugs Conference on ... ... Enanta Pharmaceuticals, a,leader in the development of small molecule anti-infective ... a new macrolide-related drug class, Bicyclolides, in the treatment,of methicillin-resistant ...
... seeks to collaborate on latest research technologies, ... Biomoda, Inc. (OTC Bulletin Board: BMOD),( http://www.biomoda.com ), ... paper entitled "New Non-Invasive Technology for the Early,Detection ... 83rd Annual,Multidisciplinary Meeting of the American Association for ...
Other Medicine Technology:Enanta Reports New Macrolide-Related Drug Class, Bicyclolides, to Combat Hospital and Community Acquired Superbug Infections, Including MRSA 2Enanta Reports New Macrolide-Related Drug Class, Bicyclolides, to Combat Hospital and Community Acquired Superbug Infections, Including MRSA 3Biomoda to Present Paper on Enhanced Technology for Early Detection of Lung Cancer at Annual SWARM Meeting 2
(Date:12/15/2009)... PLAINS, N.Y., Dec. 15 Team In ... groundbreaking charity sports training program, has ... to support blood cancer research and patient services. ... been the pre-eminent charity endurance sports training program, ... marathon, half marathon, triathlon, 100-mile century cycle ride ...
(Date:12/15/2009)... are the remarks by Lanny A. Breuer, ... the Medicare Fraud Strike Force press conference: ,, ... the enormous effort everyone at HHS is putting ... Departments have and will continue to accomplish significant ... in fighting Medicare fraud in South Florida, Los ...
(Date:12/15/2009)... North American application activity for individually ... according to the MIB Life Index(SM) . ... the past three months have lifted year-to-date (YTD) ... to flat at November,s close, -0.1%. "It ... the benefits available from life insurance," says Stacy ...
(Date:12/15/2009)... lll. Physical activity is known to reduce depression ... new study indicates that this effect stems from an ... his or her ability to achieve certain physical ... Psychosomatic Medicine . , "We base our arguments on ... a professor of kinesiology and community health at the ...
(Date:12/15/2009)... help older adults delay or reverse declining brain ... at the Johns Hopkins Bloomberg School of Public ... researchers found that seniors participating in a youth ... that support cognitive abilities important to planning and ... first of its kind to demonstrate that valuable ...
Breaking Medicine News(10 mins):Health News:$1 Billion - For Charity! 2Health News:$1 Billion - For Charity! 3Health News:Remarks by Lanny A. Breuer, Assistant Attorney General for the Criminal Division, at the Medicare Fraud Strike Force Press Conference 2Health News:Remarks by Lanny A. Breuer, Assistant Attorney General for the Criminal Division, at the Medicare Fraud Strike Force Press Conference 3Health News:MIB Life Index Reports North American Life Insurance Activity Up 3.9% in November 2Health News:MIB Life Index Reports North American Life Insurance Activity Up 3.9% in November 3Health News:Mastery of physical goals lessens disease-related depression and fatigue 2Health News:For older adults, participating in social service activities can improve brain functions 2
... play a key role in regulating cell death, a Queen’s ... scientists //that calpain may be used to promote cell death ... cell death such as in neuronal cells in the case ... of Pathology and Molecular Medicine with the Cancer Biology and ...
... of free personal care for the elderly was planned as ... the dignity and security //for everyone in old age. But ... of funding. Many medical councils are alleging that they have ... ,Earlier this week it was reported that more than 200 ...
... (Partners) and the SRM Institute of Science and Technology, ... care. // ,The MoU aimed at developing ... opportunities for its medical and nursing staff both in ... P Sathyanarayanan, said., ,The MoU was signed in ...
... to safeguard the health of pregnant women canned tuna to ... it! ,The actions and steps are being ... as much mercury as white tuna., ,Highlighting the ... in the bloodstream may harm developing nervous systems., ...
... in Mumbai with both Rahul Mahajan, now being treated in ... have supplied// him drugs, being known faces in the party ... as lifestyle drugs,are a rage with the rich and the ... rampant in party circuits or private,functions here," said a senior ...
... whose latest flick 'Fanaa' could not be released in Gujarat ... today ruled out apologising for his remarks even if it ... media at his Bandra residence, the actor said there was ... had said what the Supreme Court had earlier stated in ...
Other Medicine News:Health News:Protein’s role in regulating cell death sets direction for Alzheimer’s, Parkinson’s and cancer resea 2Health News:Drugs Part of Mumbai High Life 2
Fluoro done? Get rid of your apron quickly and easily without breaking the sterile field. A shoulder drop-away can also be used with our Stretchy-back and cummmberbund aprons. Shoulder pads and hangi...
Open armhole design with Velcro release enables removal without compromising sterile field. Loops attached at shoulders for proper hanging & storage...
This apron provides full protection all the way around. Extra wide Velcro strips provide many adjustments and a secure fit....
Unique criss-cross strapping distributes weight evenly over the torso for ultimate comfort and flexibility. Fully adjustable 2 inch belt and buckle for easy front closure....
Medicine Products: